OverviewChartTechnicalNewsTraderScreen

Tonix Pharmaceuticals Holding Cor.../  US8902608475  /

NASDAQ
2024-06-17  10:00:00 PM Chg. -0.0300 Volume Bid10:27:06 AM Ask10:27:06 AM High Low
1.1200USD -2.61% 1.28 mill.
Turnover: 1.19 mill.		 1.1000Bid Size: 700 1.1200Ask Size: 600 1.1900 1.1200
GlobeNewswire 06-17 Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual E...
GlobeNewswire 06-13 Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
GlobeNewswire 06-12 Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
GlobeNewswire 06-11 Tonix Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire 06-06 Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
GlobeNewswire 06-06 Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-150...
GlobeNewswire 06-05 Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology ...
GlobeNewswire 06-03 Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyal...
GlobeNewswire 05-30 Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine H...
GlobeNewswire 05-29 Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-150...
GlobeNewswire 05-28 Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
GlobeNewswire 05-22 Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Societ...
GlobeNewswire 05-21 Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analy...
GlobeNewswire 05-15 Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
GlobeNewswire 05-13 Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 04-24 Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
GlobeNewswire 04-01 Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Hi...
GlobeNewswire 03-28 Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
GlobeNewswire 03-25 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...
GlobeNewswire 03-21 Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Ox...
GlobeNewswire 03-20 Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch...
GlobeNewswire 03-19 Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on...
GlobeNewswire 03-12 Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
GlobeNewswire 03-11 Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonm...
GlobeNewswire 03-07 Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-1...